Professional Documents
Culture Documents
Name
Lab No.
: 222690169
Age: 7 Years
A/c Status
: P
Ref By :
Gender:
aiims
Test Name
Female
Collected
Received
Reported
: 29/8/2015 12:01:00PM
: 29/8/2015 12:01:10PM
: 31/8/2015 9:52:30AM
Report Status
: Final
Results
Units
Cholesterol Total
273.00
mg/dL
<170.00
Triglycerides
388.00
mg/dL
<150.00
HDL Cholesterol
53.00
mg/dL
40.00 - 60.00
LDL Cholesterol
142.40
mg/dL
<110.00
VLDL Cholesterol
77.60
mg/dL
<30.00
Non-HDL Cholesterol
220.00
mg/dL
Interpretation
-------------------------------------------------------------------| NCEP
| TOTAL
| TRIGLYCERIDE | LDL CHOLESTEROL |
| RECOMMENDATIONS
| CHOLESTEROL
| in mg/dL
| in mg/dL
|
|
| in mg/dL
|
|
|
|-------------------|---------------|--------------|-----------------|
| Optimal
| <170
| <150
| <110
|
|-------------------|---------------|--------------|-----------------|
| Borderline High
| 171-199
| 150-199
| 111-129
|
|-------------------|---------------|--------------|-----------------|
| High
| >=200
| 200-499
| >=130
|
|-------------------|---------------|--------------|-----------------|
| Very High
| | >=500
| |
--------------------------------------------------------------------
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial samples
1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. As per NCEP guidelines, all adults above the age of 20 years should be screened for lipid status.
Selective screening of children above the age of 2 years with a family history of premature
cardiovascular disease or those with at least one parent with high total cholesterol is recommended.
3. NCEP identifies elevated Triglycerides as an independent risk factor for Coronary Heart Disease (CHD).
4. Low HDL levels are associated with Coronary Heart Disease due to insufficient HDL being available to
participate in reverse cholesterol transport, the process by which cholesterol is eliminated from
peripheral tissues.
5. ATP III guidelines uses LDL Cholesterol as the primary target for cholesterol lowering therapy. Note that
major risk factors can modify LDL goals.
NON HDL CHOLESTEROL
----------------------------------------------------------------------| RISK CATEGORY
| LDL GOAL ( mg/dL)
| NON HDL GOAL ( mg/dL)|
|----------------------|-------------------------|----------------------|
| CHD & CHD risk
| < 100
| < 130
|
| equivalent (10 year |
|
|
| risk for CHD > 20 %) |
|
|
----------------------------------------------------------------------|----------------------|-------------------------|----------------------|
| Multiple (2+) Risk
| < 130
| < 160
|
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)
Page 1 of 6
.
LPL - PSC SAROJ DIAGNOSTIC
CENTRE
70/6, Yusuf Sarai Market, New
Delhi 110016, Ph :
011-41640132
Name
Lab No.
: 222690169
Age: 7 Years
A/c Status
: P
Ref By :
Gender:
aiims
Female
Collected
Received
Reported
: 29/8/2015 12:01:00PM
: 29/8/2015 12:01:10PM
: 31/8/2015 9:52:30AM
Report Status
: Final
Test Name
Results
Units
| Factors and 10 year |
|
|
| risk < or = 20%
|
|
|
|----------------------|-------------------------|----------------------|
| 0-1 Risk factor
| < 160
| <190
|
-----------------------------------------------------------------------
Comment:
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)
Page 2 of 6
.
LPL - PSC SAROJ DIAGNOSTIC
CENTRE
70/6, Yusuf Sarai Market, New
Delhi 110016, Ph :
011-41640132
Name
Lab No.
222690169
Age: 7 Years
A/c Status
Ref By :
Gender:
Female
aiims
Test Name
Results
Collected
Received
Reported
: 29/8/2015 12:01:00PM
: 29/8/2015 12:01:10PM
: 31/8/2015 9:52:33AM
Report Status
: Final
Units
Creatinine, 24 Hour
9.10
mg/kg/day
8.00 - 22.00
750
mL/day
650.00 - 1000.00
Body weight
15
kg
Total Protein
0.66
g/day
0.04 - 0.15
750
mL/day
650.00 - 1000.00
Interpretation
------------------------------------------| STATE
| RESULT IN g/day
|
|----------------|--------------------------|
| At rest
| 0.04 - 0.15
|
|----------------|--------------------------|
| After exercise | <0.25
|
-------------------------------------------
Note
1. Excretion of total protein in individuals is highly variable with or without kidney disease.
2. Conditions affecting protein excretion other than kidney disease are urinary tract infection, diet,
menstruation & physical activity
Comments
Diagnosis of kidney disease and response to therapy is usually obtained by quantitatively analyzing the
amount of protein excreted in urine over a 24 hour period.
-----------------------------------------------------------| TYPES OF
| TOTAL PROTEIN IN | CONDITIONS
|
| PROTEINURIA | g /day
|
|
|-------------|------------------|---------------------------|
| Heavy
| >4
| Nephrotic syndrome, Acute |
|
|
| Rapidly Progressive &
|
|
|
| Chronic
|
|
|
| Glomerulonephritis,
|
|
|
| Diabetes mellitus, Lupus |
|
|
| erythematosus, Drugs like |
|
|
| Penicillamine, Heavy
|
|
|
| metals like Gold & Mercury|
|-------------|------------------|---------------------------|
| Moderate
| 1-4
| Nephrosclerosis, Multiple |
|
|
| myeloma, Toxic
|
|
|
| nephropathies, Renal
|
|
|
| calculi
|
|-------------|------------------|---------------------------|
| Minimal
| <1
| Chronic pyelonephritis,
|
|
|
| Chronic interstitial
|
|
|
| nephritis, Renal tubular |
|
|
| diseases, Postural
|
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)
Page 3 of 6
.
LPL - PSC SAROJ DIAGNOSTIC
CENTRE
70/6, Yusuf Sarai Market, New
Delhi 110016, Ph :
011-41640132
Name
Lab No.
222690169
Age: 7 Years
A/c Status
Ref By :
Gender:
Female
aiims
Test Name
Results
------------------------------------------------------------
Collected
Received
Reported
: 29/8/2015 12:01:00PM
: 29/8/2015 12:01:10PM
: 31/8/2015 9:52:33AM
Report Status
: Final
Units
CD19
(Flow Cytometry-Single platform bead assay)
901
/uL
660.00 - 4600.00
<1.0
13.00 - 27.00
Absolute CD19
<5.0
/uL
270.00 - 860.00
Note
1. Test conducted on EDTA / Heparin whole blood. ACD samples not accepted
2. CD19 counts increase between 8.30 am to 12 noon
3. Gating strategy is CD45 vs SSC
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)
Page 4 of 6
.
LPL - PSC SAROJ DIAGNOSTIC
CENTRE
70/6, Yusuf Sarai Market, New
Delhi 110016, Ph :
011-41640132
Name
Lab No.
222690169
Age: 7 Years
A/c Status
Ref By :
Gender:
Female
aiims
Collected
Received
Reported
: 29/8/2015 12:01:00PM
: 29/8/2015 12:01:10PM
: 31/8/2015 9:52:36AM
Report Status
: Final
Test Name
Results
Units
4.70
Interpretation
------------------------------------------------------------------------------|
As per American Diabetes Association (ADA)
|
|-------------------------------------------------------------------------------|
| Reference Group
| HbA1c in %
|
|-------------------------------|-----------------------------------------------|
| Non diabetic adults >=18 years| <5.7
|
|-------------------------------|-----------------------------------------------|
| At risk (Prediabetes)
| 5.7 - 6.4
|
|-------------------------------|-----------------------------------------------|
| Diagnosing Diabetes
| >= 6.5
|
|-------------------------------|-----------------------------------------------|
| Therapeutic goals for glycemic| Age > 19 years
|
| control
| . Goal of therapy: < 7.0
|
|
| . Action suggested: > 8.0
|
|
|
|
|
| Age < 19 years
|
|
| . Goal of therapy: <7.5
|
-------------------------------------------------------------------------------
Note: 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a
diabetic patient who is recently under good control may still have a high concentration of
HbA1c. Converse is true for a diabetic previously under good control but now poorly
controlled .
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long
life expectancy and no significant cardiovascular disease. In patients with significant
complications of diabetes, limited life expectancy or extensive co-morbid conditions,
targeting a goal of < 7.0 % may not be appropriate.
Comments
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better
indicator of long term glycemic control as compared to blood and urinary glucose determinations.
ADA criteria for correlation between HbA1c & Mean plasma glucose levels
--------------------------------------| HbA1c(%) | Mean Plasma Glucose (mg/dL)|
|----------|----------------------------|
| 6
| 126
|
|----------|----------------------------|
| 7
| 154
|
|----------|----------------------------|
| 8
| 183
|
|----------|----------------------------|
| 9
| 212
|
PatientReportSCSuperPanel.HBELECTRO_SC (Version: 5)
Page 5 of 6
.
LPL - PSC SAROJ DIAGNOSTIC
CENTRE
70/6, Yusuf Sarai Market, New
Delhi 110016, Ph :
011-41640132
Name
Lab No.
222690169
Age: 7 Years
A/c Status
Ref By :
Test Name
Gender:
Female
aiims
Results
|----------|----------------------------|
| 10
| 240
|
|----------|----------------------------|
| 11
| 269
|
|----------|----------------------------|
| 12
| 298
|
---------------------------------------
Dr Beena Chandrasekhar
PhD (Life Sciences)
HOD Flowcytometry
Dr Onjal Taywade
MD (Biochemistry)
Consultant Biochemist
Collected
Received
Reported
: 29/8/2015 12:01:00PM
: 29/8/2015 12:01:10PM
: 31/8/2015 9:52:36AM
Report Status
: Final
Units
PatientReportSCSuperPanel.HBELECTRO_SC (Version: 5)
Page 6 of 6